Immune persistence after hepatitis B vaccination in infancy – Fact or fancy?

References

• Leung N. Chronic hepatitis B in Asian women of childbearing age. Hepatol Int 2009; 3:S24-31; http://dx.doi.org/10.1007/s12072-009-9142-1
   Google Scholar
• Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 8359:1099-102; http://dx.doi.org/10.1016/S0140-6736(83)90624-4
   Google Scholar
• Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HbeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984; 8383:921-6; http://dx.doi.org/10.1016/S0140-6736(84)92388-2
   Google Scholar
• Nair PV, Weissman JY, Tong MJ, Thursby MW, Paul RH, Henneman CE. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus. Gastroenterology 1984; 87:293-8; PMID:6376265
   PubMed Web of Science ®Google Scholar
• Lee PI, Lee CY, Huang LM, Chen JM, Chang MH. A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants. Vaccine 1995; 13:1685-9; PMID:8719520; http://dx.doi.org/10.1016/0264-410X(95)00108-D
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed 1997; 77:F47-51; PMID:9279183; http://dx.doi.org/10.1136/fn.77.1.F47
   PubMed Web of Science ®Google Scholar
• Assad S, Francis A. Over a decade of experience with a yeast recombinant hepatitis B vaccine. Vaccine 1999; 18:57-67; PMID:10501235; http://dx.doi.org/10.1016/S0264-410X(99)00179-6
   PubMed Web of Science ®Google Scholar
• Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 1999; 17:2661-6; PMID:10418916; http://dx.doi.org/10.1016/S0264-410X(99)00031-6
   PubMed Web of Science ®Google Scholar
• Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796-800; PMID:11694104; http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00009
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antiibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-41; PMID:15738452; http://dx.doi.org/10.7326/0003-4819-142-5-200503010-00008
   PubMed Web of Science ®Google Scholar
• Gabbuti A, Roman∫ L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 2007; 25:3129-32; PMID:17291637; http://dx.doi.org/10.1016/j.vaccine.2007.01.045
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-64; PMID:17714836; http://dx.doi.org/10.1016/j.vaccine.2007.06.059
   PubMed Web of Science ®Google Scholar
• Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, Abdo AA. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 2008; 57:404-9; PMID:18829116; http://dx.doi.org/10.1016/j.jinf.2008.08.008
   PubMed Web of Science ®Google Scholar
• FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Conference Report. Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011. Vaccine 2013; 31:584-90; PMID:23142301; http://dx.doi.org/10.1016/j.vaccine.2012.10.101
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen THH, Hsu HM, Wu TC, Kong MS, Liang DC, Ni YH, Chen CJ, Chen DS, for the Taiwan Children HCC Study Group. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005; 11:7953-7; PMID:16278421; http://dx.doi.org/10.1158/1078-0432.CCR-05-1095
   PubMed Web of Science ®Google Scholar
• Kwan LC, Ho YY, Lee SS. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 1997; 119:281-283; PMID:9363029; http://dx.doi.org/10.1017/S0950268897007796
   PubMed Web of Science ®Google Scholar
• Lok ASF. Hepatitis B vaccination in Hong Kong. J Gastroenterol Hepatol 1993; 8:S27-S29; http://dx.doi.org/10.1111/j.1440-1746.1993.tb01677.x
   Google Scholar
• Lee SS. Hepatitis B vaccination programme in Hong Kong. Public Health & Epidemiology Bulletin 1993; 2:9-12
   Google Scholar
• Leung CW. Proceedings of state of asian children - immunization. Hong Kong Journal of Paediatrics (New Series) 1999; 4:9-62
   Google Scholar
• Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978; 138:668-71; PMID:712120; http://dx.doi.org/10.1093/infdis/138.5.668
   PubMed Web of Science ®Google Scholar
• Lao TT, Chan BC, Leung WC, Ho LF, Tse KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007; 47:46-50; PMID:17434231; http://dx.doi.org/10.1016/j.jhep.2007.02.014
   PubMed Web of Science ®Google Scholar
• Suen SSH, Lao TT, Sahota DS, Lau TK, Leung TY. Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area. J Viral Hepat 2010; 17:372-8; PMID:19780946; http://dx.doi.org/10.1111/j.1365-2893.2009.01195.x
   PubMed Web of Science ®Google Scholar
• Chan OK, Lao TT, Suen SSH, Lau TK, Leung TY. Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area – have we overlooked something? Infection 2011; 39:419-26; PMID:21713427; http://dx.doi.org/10.1007/s15010-011-0151-3
   PubMed Web of Science ®Google Scholar
• Lao TT, Sahota DS, Suen SSH, Chan PK, Leung TY. Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong. Epidemiol Infect 2013; 141:2131-9; PMID:23211684; http://dx.doi.org/10.1017/S0950268812002701
   PubMed Web of Science ®Google Scholar
• Lao TT, Sahota DS, Law LW, Cheng YK, Leung TY. Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administration Region of China. Bull World Health Organ 2014; 92:782-9; PMID:25378739; http://dx.doi.org/10.2471/BLT.13.133413
   PubMed Web of Science ®Google Scholar
• Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15 Suppl:E3-6; PMID:10921373; http://dx.doi.org/10.1046/j.1440-1746.2000.02124.x
   PubMed Web of Science ®Google Scholar
• Luksamijarulkul P, Mooktaragosa A, Luksamijarulkul S. Risk factors for hepatitis B surface antigen positivity among pregnant women. J Med Assoc Thai 2002; 85:283-8; PMID:12117015
   PubMedGoogle Scholar
• Suen SSH, Lao TT, Chan OK, Lau TK, Leung TY, Chan PK. Relationship between age and prevalence of hepatitis B infection in first-year university students in Hong Kong. Infection 2013; 41:529-35; PMID:23233215; http://dx.doi.org/10.1007/s15010-012-0379-6
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Chiaramonte M, Craxì A, Franco E, Rapicetta M, Trivello R, De Mattia D, Mura I, Giammanco A, Rigo G, et al. Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination. J Infect 1991; 22:191-9; PMID:2026895; http://dx.doi.org/10.1016/0163-4453(91)91723-B
   PubMed Web of Science ®Google Scholar
• Khan F, Shams S, Qureshi ID, Israr M, Khan H, Sarwar MT, Ilyas M. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J 2011; 8:225-9; PMID:21569532; http://dx.doi.org/10.1186/1743-422X-8-225
   PubMed Web of Science ®Google Scholar
• Jeong SH, Yim HW, Yoon SH, Jee YM, Bae SH, Lee WC. Changes in the intrafamilial transmission of hepatitis B virus after introduction of a hepatitis B vaccination programme in Korea. Epidemiol Infect 2010; 138:1090-5; PMID:19951454; http://dx.doi.org/10.1017/S0950268809991324
   PubMed Web of Science ®Google Scholar
• Heininger U, Bachtiar NS, Bahri P, Dana A, Dodoo A, Gidudu J, dos Santos EM. The concept of vaccination failure. Vaccine 2012; 30:1265-8; PMID:22197579; http://dx.doi.org/10.1016/j.vaccine.2011.12.048
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53:68-75; PMID:21653306; http://dx.doi.org/10.1093/cid/cir270
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 2010; 28:623-31; PMID:19887132; http://dx.doi.org/10.1016/j.vaccine.2009.10.068
   PubMed Web of Science ®Google Scholar
• Zhu C-L, Liu P, Chen T, Ni Z, Lu L-L, Huang F, Lu J, Sun Z, Qu L. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Vaccine 2011; 29:7835-41; PMID:21816197; http://dx.doi.org/10.1016/j.vaccine.2011.07.098
   PubMed Web of Science ®Google Scholar
• Gold Y, Somech R, Mandel D, Peled Y, Reif S. Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatr 2003; 92:1158-62; PMID:14632331; http://dx.doi.org/10.1111/j.1651-2227.2003.tb02477.x
   PubMed Web of Science ®Google Scholar
• Ko SC, Schillie SF, Walker T, Veselsky SL, Nelson NP, Lazaroff J, Crowley S, Dusek C, Loggins K, Onyx K, et al. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine 2014; 32:2127-33; PMID:24560676; http://dx.doi.org/10.1016/j.vaccine.2014.01.099
   PubMed Web of Science ®Google Scholar
• Lao TT, Cheung KL, Wong V. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine 2015; 33:15-16; PMID:25017181; http://dx.doi.org/10.1016/j.vaccine.2014.05.036
   PubMed Web of Science ®Google Scholar
• Lin D-B, Wang H-M, Lee Y-L, Ling U-P, Changlai S-P, Chen C-J. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. Vaccine 1998; 16:1683-7; PMID:9713947; http://dx.doi.org/10.1016/S0264-410X(98)00050-4
   PubMed Web of Science ®Google Scholar
• Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kabieszova L, Lochman I, Mrazok J, Hozakova L, Zjevikova A, Pliskova L, et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection 2010; 38:395-400; PMID:20589522; http://dx.doi.org/10.1007/s15010-010-0039-7
   PubMed Web of Science ®Google Scholar
• Van der Sande MAB, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ, Ferrries D, Hall AJ, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. JID 2006; 193:1528-35; PMID:16652281; http://dx.doi.org/10.1086/503433
   PubMed Web of Science ®Google Scholar
• Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. J Viral Hepat 2008; 15:14-9; PMID:18088240
   PubMed Web of Science ®Google Scholar
• Lin C-C, Chang C-K, Huang Y-L, Tseng H-F. Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: an implication for boosting. Vaccine 2007; 25:8508-11; PMID:18006122; http://dx.doi.org/10.1016/j.vaccine.2007.10.018
   PubMed Web of Science ®Google Scholar
• Chan PKS, Ngai KLK, Lao TT, Wong MC, Cheung T, Yeung ACM, Chan MCW, Luk SWC. Response to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination. PLoS ONE 2014; 9(9):e107163; PMID:25198289; http://dx.doi.org/10.1371/journal.pone.0107163
   PubMedGoogle Scholar
• Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study. Infection 2009; 37:340-3; PMID:19629385; http://dx.doi.org/10.1007/s15010-008-8252-3
   PubMed Web of Science ®Google Scholar
• Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth. A 15-year follow-up study. Pediatr Infect Dis J 2008; 27:881-5; PMID:18756185; http://dx.doi.org/10.1097/INF.0b013e31817702ba
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Roman∫ L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al and the Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-84; PMID:16226616; http://dx.doi.org/10.1016/S0140-6736(05)67568-X
   PubMed Web of Science ®Google Scholar
• Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415-20; PMID:15565627; http://dx.doi.org/10.1002/hep.20490
   PubMed Web of Science ®Google Scholar
• Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo HS, Huang LM, Chen DS, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. JID 2008; 197:1419-1426; PMID:18444799; http://dx.doi.org/10.1086/587695
   PubMed Web of Science ®Google Scholar
• Dent E, Selvey CE, Bell A, Davis J, McDonald MI. Incomplete protection against hepatitis B among remote Aboriginal adolescents despite full vaccination in infancy. Commun Dis Intell Q Rep 2010; 34:435-9; PMID:21413528
   PubMedGoogle Scholar